- $154.76bn
- $140.08bn
- $62.58bn
- 88
- 93
- 71
- 97
Pfizer Inc - EyeCyte, Inc. Secures Series A Funding from Pfizer
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of June 4 Pfize
AnnouncementPfizer Inc - Pfizers Growing Strength in Oncology
AnnouncementPfizer Inc - New Pfizer Oncology Data Across Numerous Cancer Types to be Present
AnnouncementPfizer Inc - Pfizer Announces Discontinuation of Phase III Clinical Trial for Pa
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of Pfizer Parti
AnnouncementPfizer Inc - Pfizer Will Immediately Seek to Appeal Lipitor Patent Ruling in Nor
AnnouncementPfizer Inc - New Vice President
AnnouncementPfizer Inc - Pfizer Names Sally Susman Senior Vice President of Worldwide Commun
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of April 17 Con
AnnouncementPfizer Inc - Norvasc Patent
AnnouncementPfizer Inc Pfizer Plans to Reconfigure Global Plant Network
AnnouncementPfizer Inc - Pfizer Successfully Completes Tender Offer for Shares of Encysive P
AnnouncementPfizer Inc - Regulatory Approval
AnnouncementPfizer Inc - Long-Term Data Reinforce Safety and Efficacy Profile of Pfizers Ne
AnnouncementPfizer Inc - Pfizer Discontinues Development Program for Its Phase 3 Obesity Com
AnnouncementPfizer Inc - Sutent Significantly Increases Progression Free Survival for Patien
AnnouncementPfizer Inc Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In No
Announcement